29.9 C
Byron Shire
February 5, 2023

Leukaemia drug could replace chemotherapy

Latest News

Natural history

While I have not the informed authority to confirm John Bradley’s musings on the birds that seem to be...

Other News

Old ANZ Mullum

The old ANZ Bank building on Burringbar Street in Mullum is now a bathhouse; such yuppy city indulgence to...

V-Day returns to Byron Bay, February 14

A mass global action, One Billion Rising, which aims to end violence against women and children, is planned for V-Day on February 14, Main Beach, Byron Bay from 7am.

Letters – 1 February 2023

The Echo loves your letters and is proud to provide a community forum on the issues that matter most to our readers and the people of the NSW north coast. So don’t be a passive reader, send us your epistles.

Better outcomes start with teachers who believe in inclusive education

For all students – particularly those with additional needs – a teacher who doesn't believe in inclusive education can be harmful.

Appeal for flag stolen from Bruns

The two Aboriginal flags that fly high over the Brunswick River Bridge on Invasion Day have become a potent symbol of survival and solidarity for many in the Shire. 

Mother and Daughter Stop Logging in Yarratt Forest

Two women who grew up in the Manning Valley are currently suspended from trees with  ropes connected to, and stopping, logging in Yarratt Forest north of Taree.

The successful trial of a new leukaemia drug could herald the end of chemotherapy as the main weapon against the blood cancer, says an Australian specialist.

The results of human trials show the drug ibrutinib could save people with chronic lymphocytic leukaemia (CLL) after the disease develops resistance to chemotherapy.

It gives them a much better chance of survival than the standard treatment, according to a presentation at the annual meeting of the American Society of Clinical Oncology.

More than four in 10 patients on ibrutinib entered remission, compared with four in 100 on the standard treatment, says Dr Con Tam of Melbourne’s Peter MacCallum Cancer Centre.

CLL is the most common form of leukaemia in Australia and other Western countries. About 50 percent of people with the disease never develop serious symptoms and don’t need treatment.

But the disease is life-threatening for the other half and eventually becomes resistant to chemotherapy.

After one year, overall survival on ibrutinib was 90 per cent, compared with 81 per cent on standard treatment.

‘These resistant patients have no other treatment option,’ says Dr Tam, co-author of a New England Journal of Medicine report on the international trial involving 391 patients.

And unlike chemotherapy, ibrutinib has few side effects. It works by disabling an enzyme crucial for leukaemia’s survival.

Patients in the trial responded quickly and reported a greatly improved quality of life, says Dr Tam.

The drug was so effective its superiority was confirmed after an average follow-up of only nine months, and approval of its use in the US has been fast-tracked.

‘This pill works extremely well when chemotherapy stops working,’ says Dr Tam, who participated in the Australian trial.

‘The next question is whether this should be the main treatment for leukaemia. We might not need chemotherapy at all.’

Hundreds of Australians a year could benefit from the US-developed drug, says Dr Tam.

But Australian approval is around a year away and it could take two years to be listed on the pharmaceutical benefits scheme.


Support The Echo

Keeping the community together and the community voice loud and clear is what The Echo is about. More than ever we need your help to keep this voice alive and thriving in the community.

Like all businesses we are struggling to keep food on the table of all our local and hard working journalists, artists, sales, delivery and drudges who keep the news coming out to you both in the newspaper and online. If you can spare a few dollars a week – or maybe more – we would appreciate all the support you are able to give to keep the voice of independent, local journalism alive.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Community advocacy

I am a small business owner of Byron Central Apartments. Tamara Smith MP has recently supported us on two separate occasions advocating effectively with...

Swivel by name, drivel by nature

The lack of authenticity of Byron Councillor, Mark Swivel, does not come as a surprise from this side of the fence. A well-to-do lawyer...

Land values rise

Your cover story on 25 January claims that land valuation rises could herald increases in Council rates. This is potentially misleading. A council’s total...

Go Thistles!

Lismore Thistles Soccer Club has launched the Thistles Acceleration Program, in the process becoming the city’s only player development academy.